Recombinant Human UPK2 Protein，His

UPK2 (Uroplakin 2) is a crucial component of the uroplakin family, primarily expressed in the bladder's urothelium, where it plays a significant role in maintaining the integrity and function of the bladder lining. Research into UPK2 has gained substantial interest due to its involvement in urinary tract physiology and its potential implications in various urological conditions, including bladder cancer. UPK2 contributes to the formation of the urothelial umbrella cells, which serve as a barrier against toxic substances in urine and prevent permeability. Moreover, aberrant UPK2 expression has been associated with pathological alterations in bladder tissues, indicating that it may serve as a biomarker for disease progression. Investigating UPK2 as a recombinant protein is essential for understanding its structural characteristics, interactions, and functional roles in cellular processes. The production of UPK2 as a recombinant protein allows for detailed study of its biochemical properties and facilitates the development of potential therapeutic strategies targeting urological diseases. Additionally, it provides insights into the mechanisms of bladder cell differentiation and regeneration, contributing to a broader understanding of bladder health and disease. Researchers are exploring the therapeutic potential of UPK2, particularly in the context of bladder cancer and other urothelial disorders, where targeting its pathways could lead to novel treatment options. Thus, ongoing research on UPK2 recombinant protein not only enhances our fundamental knowledge of urothelial biology but also paves the way for innovative clinical approaches to manage urinary tract diseases effectively.